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Background: PCV ORF2 capsid protein was predicted to contribute to the control of replication via an interaction
between the Cap and Rep proteins in the nucleoplasm. We previously showed that the nuclear localization signal
(NLS) on the capsid protein plays an accessory role in the replication of PCV in vitro. To further evaluate the in vivo
characteristics of NLS-chimeric PCV DNA clones, BALB/C mice were inoculated intranasally and intraperitoneally with
the DNA clones.
Results: As expected, no gross lesions were detected during the study of the inoculated animals. The chimeric
PCV12-, PCV1-NLS2- and PCV2-NLS1-inoculated animals had significantly fewer and less severe histopathological
lesions in lymphoid tissues than the PCV2-inoculated animals (P < 0.05). PCV12 induced a specific antibody response
against PCV2 ORF2 comparable to that induced by wild-type PCV2 but demonstrated a shorter period of viremia
and much lower level of virus loads in sera than those in PCV2-inoculated mice. Remarkably, the PCV2-NLS1 and
PCV1-NLS2 chimeras replicated in inoculated mice and induced specific antibody responses but failed to produce
viral antigens in the lymph nodes or a detectable viremia.
Conclusions: The chimeric PCV2-NLS1 and PCV1-NLS2 demonstrated a lower replication level as compared with
wild type of PCV2 or PCV1 in vivo, suggesting that ORF2 NLSs played an accessory role in PCV replication. The
chimeric PCV12 is a good candidate for vaccination against PCV2 infection.
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Porcine circovirus type 2 (PCV2) is the primary causa-
tive agent of postweaning multisystemic wasting syn-
drome (PMWS), which was first described in 1991 in
Saskatchewan, Canada [1,2]; PCV1 was identified in a
porcine kidney cell line (PK-15) and was non-cytopathic
in pigs [3]. The genomes of both PCV1 and PCV2 con-
tain a conserved stem-loop structure and an identical
essential core element at the origin of DNA replication
and replicate via a rolling cycle replication mechanism
[4-8]. Further study revealed that the cis- and trans-acting
replication factors of PCV1 and PCV2 were functionally
interchangeable, indicating that the replication strategy* Correspondence: whfang@zju.edu.cn
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reproduction in any medium, provided the ormay not be the main factor determining the distinct
propagation efficiencies and pathogenicities of PCV1 and
PCV2 [8].
In geminiviridae, which use the same mode of replica-
tion as PCV, failed nuclear localization of the coat protein
results in a drastic reduction in viral genomic ssDNA
accumulation, indicating that the capsid protein mediates
viral DNA transport and plays a role in controlling viral
DNA copy number [9,10]. The PCV capsid protein is
expressed late in the infection cycle and colocalizes to the
nucleoplasm together with the replication protein, indica-
ting that,in addition to its role in encapsidation, the PCV
capsid protein may contribute to control of replication via
the interaction between Cap and Rep in the nucleoplasm
[11,12]. Nuclear translocation of the PCV1 and PCV2
ORF2 proteins was mediated by functional stretches of
nuclear localization signals (NLS) [13,14]. In a previous
study, we found that the NLS sequences of the PCV1 andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with respect to nuclear import and viral propagation, and
the ORF2 NLS plays an accessory role in PCV replication
in vitro [15]. In the present study, the in vivo characteris-
tics of chimeric PCV DNA clones containing heteroge-
neous capsid protein NLSs were studied.
Results
In vitro characterization of the PCV12 DNA clone
The PCV1, PCV2, PCV2-NLS1 and PCV1-NLS2 DNA
clones were shown to be infectious in vitro in a previous
study [15]. Detection of PCV2 capsid protein in approxi-
mately 10% of transfected cells (Figure 1B) using anti-
bodies to the PCV2 ORF2 protein indicated that the
PCV12 chimeric DNA clone could replicate in vitro and
express the PCV2 capsid protein, as predicted. A 928-bp
fragment that could only be the product of circular
PCV12 genomes was amplified by primers R63 and F894
[15], while no large-sized product corresponding to the in-
put recombinant plasmid was observed (data not shown).
The initial titers of PCV1, PCV2 and PCV12 virus pro-
duced by transfected cells were all approximately 103.5
TCID50/ml. The levels of all three viruses increased over
the course of passaging and stabilized after approximately
20 passages at 105.6, 105.0 and 104.9 TCID50/ml, respect-
ively (Figure 2A. The lifecycle of PCV12 was examined
further by one-step growth analysis. The infectious titers
of PCV1, PCV2 and PCV12 were all approximately 102.0
TCID50/ml after initial infection (Figure 2B) and increased
gradually for all three viruses from 12 to 96 hours. PCV1
propagated most efficiently to reach a significantly higher
titer of 104.3 TCID50/ml by 96 h post-infection, whereas
the infectious titers of PCV2 and PCV12 reached 103.6
and 103.5 TCID50/ml, respectively. This difference is most
likely due to an adaptation of PCV1 that favors its growthA
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Figure 1 (A) A schematic of the construction of the infectious PCV12
transfected in PK-15 cells. The cells were stained with a polyclonal antibody
genome organization of the resulting chimeric PCV12 virus.in PK-15 cells because the PCV1 isolates used in these
studies originated from PK-15 cell lines.
Immunogenicity of the PCV1, PCV2, PCV12, PCV1-NLS2
and PCV2-NLS1 DNA clones in vivo
Prior to inoculation, twenty randomly selected mice
were tested negatively for PCV1 and PCV2 antibodies.
The cut-off values (mean ± 3 SD) were calculated using
the OD values of serum samples from normal animals as
a baseline.
Control animals in MEM-inoculated group were all
negative for both PCV1 and PCV2 antibodies throughout
the study (Table 1). In the group 2 and group 5 animals
inoculated with PCV1 and PCV1-NLS2, seroconversion to
PCV1 ORF2 first occurred at 14 dpi. The remaining mice
in group 2 displayed antibodies to PCV1 by 28 dpi and
remained positive until 42 dpi, while only six mice in
group 5 seroconverted by the end of the study.
In the PCV2-inoculated group, seroconversion to PCV2
ORF2 antibodies was first detected in two of the four mice
at 14 dpi. The remaining PCV2-inoculated mice displayed
antibodies to to PCV2 by 28 dpi and remained positive
until the end of the study at 42 dpi. In the group 4 mice
inoculated with PCV12, seroconversion to PCV2 ORF2
specific antibodies first occurred at 14 dpi, and the rest of
the mice seroconverted by 42 dpi. In mice inoculated with
PCV2-NLS1, seroconversion to PCV2 antibodies was also
first detected at 14 dpi and was found in three of the four
mice by 28 dpi and 42 dpi.
The dynamics of PCV ORF2-specific antibody pro-
duction in inoculated animals over the course of the ex-
periment showed that all the DNA clones induced
increasingly specific antibodies (Figure 3). By the end
of the study at 42 dpi, the mean antibody levels
in PCV1-, PCV2- and PCV12-inoculated mice wereB C
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Figure 2 In vitro viability (A) and one-step growth curve (B) of PCV12 produced by transfection of PK-15 cells with DNA clone. The
in vitro viability and growth characteristics of PCV1 and PCV2 were already evaluated in a previous study [15].and were only used for comparison
here. The infectious titers were determined by IFA according to the Reed-Muench method.
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and PCV2-NLS1-inoculated mice were much lower
than those induced by PCV1, PCV2 and PCV12.
In vivo pathogenicity of the PCV1, PCV2, PCV12,
PCV1-NLS2 and PCV2-NLS1 DNA clones
Clinical and pathological evaluation of inoculated mice
For all the inoculated animals, no clinical signs or gross
lesions were observed throughout the experimental period.
Sections of spleen, lung and mesenteric lymph nodes were
evaluated microscopically, and the results are shown in
Table 2. No microscopic lesions were observed in either
the PCV1-inoculated group or the PCV1-NLS2-inoculated
group mice at any time following inoculation. Only one
mouse from the PCV2-inoculated group showed mild
histiocytic broncho-interstitial pneumonia when examined
at 28 dpi, and no lung lesions were observed in any mice
from the other groups. Mild lymphoid depletion and histio-
cytic infiltration were detected in the spleens of four PCV2-
and two PCV12-inoculated mice, as well as in one spleen
sample from the PCV2-NLS1-inoculated group.Table 1 Seroconversion to PCV1 or PCV2 antibodies in DNA-i
Group Inoculuma Antibodies
tested 0
1 MEM PCV1 ORF2 0/4
PCV2 ORF2 0/4
2 PCV1 DNA PCV1 ORF2 0/4
3 PCV2 DNA PCV2 ORF2 0/4
4 PCV12 DNA PCV2 ORF2 0/4
5 PCV1-NLS2 DNA PCV1 ORF2 0/4
6 PCV2-NLS1 DNA PCV2 ORF2 0/4
aMEM was used as a negative control.
bFour mice were tested in each group at different time points following inoculationCompared with those in other tissues, lesions in lymph
node from inoculated animals occurred with higher
frequency and severity. Four PCV12- and two PCV2-
NLS1-inoculated mice showed very mild lesions in the
lymph nodes. However, mild-to-moderate lymph node
lesions were detected in thirteen of the sixteen mice in
the PCV2-inoculated group at 14, 28 and 42 dpi. The
lesion scores for mice in the PCV12- and PCV2-NLS1-
inoculated groups showed no significant differences versus
those for mice in the PCV1-inoculated group (Table 2,
Figure 4A) but were significantly different from those for
mice in the PCV2-inoculated group (P < 0.05).Evaluation of viremia by TaqMan PCR in sera of inoculated
mice
Control animals in the MEM-inoculated group were all
negative for PCV1- or PCV2-associated viremia through-
out the study (Table 3). Viral DNA was not detected in
the sera of mice inoculated with PCV1-NLS2 in group 5
or in the sera of mice inoculated with PCV2-NLS1 innoculated and control mice
No. of sero-positive mice/no. testedb at dpi:
7 14 28 42
0/4 0/4 0/4 0/4
0/4 0/4 0/4 0/4
0/4 2/4 4/4 4/4
0/4 2/4 4/4 4/4
0/4 2/4 3/4 4/4
0/4 1/4 2/4 3/4
0/4 2/4 3/4 3/4
.
Figure 3 PCV1- or PCV2-specific antibody dynamics in inoculated
and control mice as determined by indirect ELISA. Values at different
dpi represent the mean OD492 of four mice per group; error bars
represent the standard deviations.
Table 2 Histopathological lesions in tissues of inoculated and
Group Inoculuma dpi
Lung
























aMEM was used as a negative control.
bFour mice were tested in each group at different time points following inoculation
cValues in parentheses are mean scores (0, normal; 1, mild; 2, moderate; 3, severe) f
Different superscripts (I and II) indicate that the mean scores differ significantly betw
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viremia was first detected in two animals at 7 dpi and
lasted until the end of the study, with a total of eleven out
of twelve mice showing viremia. The group 2 and group 4
mice inoculated with PCV1 and PCV12 displayed shorter
periods of viremia, the earliest-occurring instances of
which were detected at 7 dpi in one mouse in each group
and the latest-occurring instances of which were detected
at 14 dpi in one and two mice per group, respectively. The
copy number of PCV2 genomic DNA in PCV2-inoculated
mice ranged from 102.3 to 103.8 copies/0.2 ml and peaked
at 28 dpi (Figure 4B). Viral loads in PCV1- and PCV12-
inoculated mice were 102.7 and 102.3 copies/0.2 ml,
respectively, at 14 dpi and 103.6 and 102.9 copies/0.2 ml,
respectively, at 28 dpi. Of further note, the viral loads in
mice from the PCV1- and PCV12-inoculated groups
were much lower than those in PCV2-inoculated mice
(P < 0.05) over the course of the study.control mice
No. of mice with microscopic lesions/no. tested at dpib
Lymph node c Spleen
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.00)I 0/4 (0.0)I
0/4 (0.00)I 0/4 (0.0)I
2/4 (0.5)I 0/4 (0.0)I
4/4 (1.0)II 1/4 (0.25)I
4/4 (1.5)II 2/4 (0.75)II
3/4 (1.75)II 1/4 (0.5)II
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.00)I
2/4 (0.5)I 1/4 (0.25)I
2/4 (0.5)I 1/4 (0.25)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
0/4 (0.0)I 0/4 (0.0)I
1/4 (0.25)I 1/4 (0.25)I
1/4 (0.25)I 0/4 (0.0)I
.
or lymphoid depletion and histiocytic infiltration of 4 mice in each group.
een the groups (P < 0.05).
Figure 4 (A) Evaluation of histopathological lesions within
lymph nodes. The values shown represent the mean scores of four
mice per group. The average lesion values of mice in groups
indicated by ** were significantly different from those of mice in
groups indicated by *. (B) Quantification by real-time PCR of viremia
in serum samples from inoculated mice. The values shown represent
the mean DNA loads in the sera of four mice per group; error bars
represent the standard deviations.
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Immunohistochemical detection of PCV ORF2-specific
antigen was performed on lymph nodes from mice
necropsied at 28 and 42 dpi. As shown in Table 4, lymph
nodes from the MEM-, PCV1-, PCV1-NLS2- and
PCV2-NLS1-inoculated mice were negative for both
PCV1 ORF2 and PCV2 ORF2 antigen. In the PCV2-
inoculated group, PCV2 ORF2 protein was detected in




2 PCV1 DNA 0/4
3 PCV2 DNA 0/4
4 PCV12 DNA 0/4
5 PCV1-NLS2 DNA 0/4
6 PCV2-NLS1 DNA 0/4
aMEM was used as negative control.
bFour mice were tested in each group at different time points following inoculationcollected at 28 dpi and four out of the four animals col-
lected at 42 dpi. PCV2 ORF2 was also detected in the
lymph nodes of only one out of the four mice collected
at both 28 and 42 dpi from the chimeric PCV12-
inoculated group. Furthermore, the mean scores repre-
senting the levels of PCV ORF2 antigen in the tissues of
PCV12-inoculated animals were similar to those of the
control and PCV1-inoculated groups but were signifi-
cantly different from the mean scores of PCV2-
inoculated mice at either 28 or 42 dpi (P < 0.05).
The viral genomic DNAs were amplified from lymph
nodes of inoculated mice as described in the previous
study [15]. Sequencing of the DNAs showed that all the
viruses were genetically stable in vivo during the course
of study, as no additional mutations or reversions were
found in the genomes (data not shown).
Discussion
Antibodies to PCV2 have been detected in various spe-
cies other than pigs, including humans, mice and cattle
[16-18]. The mechanism of PCV2-induced pathogenesis
in mice is unknown. Quintana et al. reported that no
microscopic lesions reminiscent of those observed with
PCV2 infection in pigs were detected in inoculated mice,
which might be explained by the low dose of the inocu-
lum and the administration route [19]. However, several
studies in which PCV2 was shown to be capable of repli-
cating in mice and caused lesions similar to those
observed in pigs have demonstrated that mice can in-
deed be used for an experimental model of PCV2 infec-
tion [20-22]. We showed previously that the NLS
sequences of the viral capsid proteins were functionally
interchangeable between PCV1 and PCV2 with respect
to nuclear import and viral propagation. Those findings
also revealed that PCV ORF2 NLSs were involved in
viral replication in vitro. However, we found that the
ORF2 NLS was not responsible for the differences in the
in vitro growth characteristics of PCV1 and PCV2 [15].
In the present study, BALB/c mice were introduced as
an animal model for evaluating the immunogenicity and
pathogenicity of PCV2 and chimeric PCVs using bothl mice by Taqman PCR
No. of mice with viremia/no. tested at dpib:
7 14 28 42
0/4 0/4 0/4 0/4
0/4 1/4 1/4 0/4
2/4 4/4 4/4 3/4
0/4 1/4 2/4 0/4
0/4 0/4 0/4 0/4
0/4 0/4 0/4 0/4
.
Table 4 Immunohistochemical detection of viral antigen in lymph nodes of inoculated mice
Group Inoculuma No. of IHC positive mice /no. tested at dpib:
28 42
1 MEM 0/4(0.0)I 0/4(0.0)I
2 PCV1 DNA 0/4(0.0)I 0/4(0.0)I
3 PCV2 DNA 3/4(0.75)II 4/4(1.0)II
4 PCV12 DNA 1/4(0.25)I 1/4(0.25)I
5 PCV1-NLS2 DNA 0/4(0.0)I 0/4(0.0)I
6 PCV2-NLS1 DNA 0/4(0.0)I 0/4(0.0)I
aMEM was used as a negative control.
bFour mice were tested in each group at different time points following inoculation. Values in parentheses are mean levels of positive signal in lymph nodes.
Different superscripts (I and II) indicate that the mean scores differ significantly between the groups (P < 0.05).
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described elsewhere [16,20].
In the present study, no gross lesions were observed in
the inoculated animals at any point in the experimental
course. On the microscopic level, the chimeric PCV12-,
PCV1-NLS2- and PCV2-NLS1-inoculated animals showed
statistically similar lesion scores to those of the nonpatho-
genic PCV1-inoculated mice but had significantly fewer
(P < 0.05) and less severe histopathological lesions than the
PCV2-inoculated animals. Scoring of the specific viral anti-
gen levels detected in lymph nodes by IHC resulted in a
mean score for PCV12-inoculated animals that was signifi-
cantly lower (P < 0.05) than that for PCV2-inoculated mice,
suggesting that there is less viral antigen present within the
lymphoid tissues after PCV12 infection. However, IHC
showed no detectable antigen in the lymph nodes of
PCV2-NLS1- and PCV1-NLS2- inoculated animals. Meas-
urement of viral DNA in the sera by real time PCR also
revealed no detectable viremia in the PCV1-NLS2- or
PCV2-NLS1-inoculated mice during the study. The lack of
viral antigen in the lymph nodes, the absence of viremia
and the reduced number and severity of microscopic
lesions in PCV2-NLS1- and PCV1-NLS2-inoculated ani-
mals could be due to the lower replication levels of the two
chimeric viruses in vivo. However, the absence of detectable
chimeric PCV1-NLS2 and PCV2-NLS1 viremia in sera did
not affect the rate of seroconversion, as all the inoculated
groups produced serum antibodies against PCV capsid pro-
tein by the end of the study, as consistent with a previousTable 5 Primers used in the construction of the PCV12 DNA c




DNA clone MspI-r CGTTACCGGAGAAGAAGACAC
EcoRV-f12 GCGATATCATGGAGAAGAAGT
EcoRI-r12 CCGAATTCTCTTTCACTTTTATA
aThe restriction enzyme sites are underlined.finding [23]. In addition, PCV1- and PCV12-inoculated
mice had shorter periods of viremia and lower viral loads
in their sera than did the PCV2-inoculated mice.
Conclusions
The availability of chimeric DNA clones enables us to
further study the viral replication mechanism and the
functional relationships between viral genes. The present
study revealed that the chimeric PCV12 DNA clone
induced a specific antibody response to PCV2 ORF2
comparable to that induced by PCV2 but had limited
pathogenicity in vivo similar to nonpathogenic PCV1,
suggesting that chimeric PCV12 could be a candidate
for vaccination against PCV2 infection. Most remark-
ably, the PCV1-NLS2 and PCV2-NLS1 chimeras also
replicated and induced specific antibody responses
in vivo. However, the lack of viral antigen in lymph
nodes and absence of detectable viremia revealed that
PCV1-NLS2 and PCV2-NLS1 had lower replication
levels in vivo compared with wild-type PCV2 or PCV1,
suggesting that the PCV1 and PCV2 ORF2 NLSs were
functionally interchangeable and played an accessory
role in PCV replication.
Methods
Construction of the chimeric PCV12 DNA clone
The strategy used for PCV12 DNA clone construction
was similar to that used for PCV1 DNA clone construc-
tion [15]. Briefly, PCV2 ORF2 was amplified with primerlone
Primer location Application
ATACGTCATC 1694-1724 nt PCV1 ΔORF2
ACGATGTGATAAC 995-1029 nt
G 1029-1051 nt PCV2 ORF2
1696-1716 nt
TGTTGT 649-675 nt Duplicate
GGATG 1721-1748 nt
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AflII-r were then used to amplify the whole recombinant
plasmid sequence of pUC-PCV1, including the pUC-18
vector and the PCV1 genome without its ORF2 se-
quence. The expected PCR products were ligated together
to create recombinant plasmid pUC-PCV12, which con-
tained the PCV2 capsid gene cloned into the backbone of
the PCV1 genome. The PCV12 genome was excised and
recircularized. The duplicated fragment was then ampli-
fied from the circularized PCV12 genome with primers
EcoRV-f12 and EcoRI-r12 and subcloned into pUC-
PCV12 to generate the chimeric PCV12 DNA clone pIS-
PCV12 (Figure 1A).
In vitro characterization of PCV12
To determine the infectivity and in vitro growth charac-
teristics of the progeny PCV12 viruses, PK-15 cells
grown to 80% confluency in 6-well plates were trans-
fected with 20 μg of PCV1, PCV2 and PCV12 DNA
clone as described previously [15]. The cells in each well
were collected 5 days post-transfection and were then
frozen and thawed three times. Subsequently, the cell
lysates were used to inoculate fresh PK-15 cells growing
in T-25 flasks, which were incubated for five days and
then passaged serially 26 times. The in vitro viability and
growth activity of the progeny viruses were evaluated by
IFA as described previously [15].
In vivo experimental design
One hundred and sixteen 7-week-old BALB/C mice
were used for the in vivo experiment, twenty of which
were randomly selected before inoculation to undergo
nucleic acid and serological screening for PCV to con-
firm that the animals used in the study were initially
PCV-free. The remaining mice were divided into six
groups of sixteen animals each and housed in pens in
separate rooms, where they were acclimatized for 7 days
before inoculation. As a negative control, the mice in
group 1 were inoculated intranasally and intraperitone-
ally with culture fluid (MEM). Mice in groups 2 and 3
were inoculated intranasally and intraperitoneally with
0.2 ml (50 μg) of the PCV1 and PCV2 DNA clones.
Group 4 animals were inoculated with 0.2 ml (50 μg) of
the PCV12 DNA clone. Animals in groups 5 and 6 were
inoculated with 0.2 ml (50 μg) of the chimeric PCV1-
NLS2 and PCV2-NLS1 DNA clones [15]. All mice were
monitored daily for health status and possible clinical
signs. Four mice in each group were euthanized by
bleeding at 7, 14, 28 and 42 days post-inoculation (dpi).
Blood and tissue samples were collected from euthanized
mice and stored at −80°C for further studies. The animal
experiments in this study were approved by the Animal
Welfare Committee of Zhejiang University (protocol No.
20100134).Serological study
Antibodies to PCV1 or PCV2 in the serum of each
euthanized mouse were detected by modified indirect
ELISA based on the recombinant ORF2 capsid protein
of PCV1 or PCV2 as described previously [24,25].
Pathological analysis
For microscopic study, sections of spleen, lung and mes-
enteric lymph nodes were fixed in 4% phosphate-buffered
paraformaldehyde. The sections were then dehydrated,
embedded in paraffin, stained with hematoxylin and eosin
(HE) and finally evaluated under a microscope. Lesion
scores for lymphoid tissues were estimated in blinded
samples based on the level of lymphoid depletion and
histiocytic infiltration, with scores ranging from 0 (normal
or no lymphoid depletion) to 3 (severe lymphoid depletion
and histiocytic infiltration).
Viral detection by taqman PCR
Blood samples from euthanized mice were collected dur-
ing necropsy and were stored at −80°C before DNA ex-
traction. Viral DNA was extracted from serum using the
QIAamp DNA Blood kit (QIAGEN, USA) according to
the manufacturer’s instructions. The amount of PCV
DNA obtained from serum was determined using PCV1
or PCV2 ORF2-based primer pairs and probes [15].
Immunohistochemistry (IHC) analysis
Specific antigens of PCV1, PCV2 and the three chimeric
viruses were detected by IHC in paraffin-embedded
sections of lymph node collected at 28 and 42 dpi using
polyclonal antiserum to PCV1 or PCV2 according to the
procedures described previously [23]. The polyclonal
antiserum to PCV1 or PCV2, which was raised in rabbits
by immunization with PCV1 and PCV2 viral proteins,
have been confirmed as type-specific by immunofluores-
cence assay and western blot [25]. The amounts of specific
antigen distributed in the tissues were scored blindly on a
scale of 0 (for no signal) to 3 (for a strong positive signal).
Statistical analysis
Results were presented as averages ± the standard devia-
tions. Associations between rates of pathological lessions
(normal, mild, moderate and severe) and amounts of viral
antigens in the lymph nodes (negative, mild, moderate and
strong) were assessed using the χ2 test. Differences were
considered significant when P < 0.05.
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